Compass Therapeutics (CMPX) Other Working Capital Changes (2023 - 2026)
Compass Therapeutics' Other Working Capital Changes history spans 4 years, with the latest figure at $87000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 134.39% to $87000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$4.8 million, a 98.5% decrease, with the full-year FY2025 number at -$5.1 million, down 320.38% from a year prior.
- Other Working Capital Changes hit $87000.0 in Q1 2026 for Compass Therapeutics, up from -$4.8 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for CMPX hit a ceiling of $5.0 million in Q2 2024 and a floor of -$6.5 million in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$572923.1 across 4 years, with a median of -$41000.0 in 2025.
- Biggest five-year swings in Other Working Capital Changes: surged 690.13% in 2024 and later tumbled 729.29% in 2025.
- Tracing CMPX's Other Working Capital Changes over 4 years: stood at $4.1 million in 2023, then plummeted by 114.08% to -$577000.0 in 2024, then tumbled by 729.29% to -$4.8 million in 2025, then skyrocketed by 101.82% to $87000.0 in 2026.
- Business Quant data shows Other Working Capital Changes for CMPX at $87000.0 in Q1 2026, -$4.8 million in Q4 2025, and -$37000.0 in Q3 2025.